Related Experiment Video
Updated: Aug 8, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma
Hye-Rim Park1, Woon Won Jung, Patrizia Bacchini
1Department of Pathology, College of Medicine, Hallym University, Anyang, Republic of Korea.
Pathology, Research and Practice
|May 9, 2006
Summary
Ezrin protein is highly expressed in high-grade osteosarcoma, correlating with poor patient outcomes. Low-grade osteosarcomas show no ezrin expression, suggesting its role in tumor progression and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ezrin is a cytoskeleton linker protein implicated in cancer cell growth and metastasis.
- High ezrin expression correlates with poor prognosis in pediatric osteosarcoma patients.
Purpose of the Study:
- To investigate the role of ezrin overexpression in osteosarcoma metastasis.
- To compare ezrin expression in high-grade versus low-grade osteosarcoma lesions.
Main Methods:
- Immunohistochemistry was used to assess ezrin protein levels in 32 high-grade and 21 low-grade osteosarcoma specimens.
- Western blotting analyzed ezrin protein expression in three human osteosarcoma cell lines.
- Real-time quantitative PCR evaluated ezrin mRNA levels in osteosarcoma cell lines and control fibroblasts.
Main Results:
- Ezrin immunoreactivity was found in 43.7% of high-grade osteosarcoma specimens.
- All low-grade osteosarcoma samples were negative for ezrin.
- Osteosarcoma cell lines exhibited elevated ezrin mRNA levels compared to control cells.
Conclusions:
- Ezrin expression is significantly higher in high-grade osteosarcomas than low-grade ones.
- Ezrin may play a role in osteosarcoma progression and metastasis.
- Further research is required to determine ezrin's clinical utility in osteosarcoma patient management.
